The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells.

cancer stem cell diffuse intrinsic pontine glioma diffuse midline glioma glioblastoma glioma stem cell high grade glioma recurrence subventricular zone

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 07 10 2020
accepted: 09 12 2020
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 13 2 2021
Statut: epublish

Résumé

Both in adult and children, high-grade gliomas (WHO grades III and IV) account for a high proportion of death due to cancer. This poor prognosis is a direct consequence of tumor recurrences occurring within few months despite a multimodal therapy consisting of a surgical resection followed by chemotherapy and radiotherapy. There is increasing evidence that glioma stem cells (GSCs) contribute to tumor recurrences. In fact, GSCs can migrate out of the tumor mass and reach the subventricular zone (SVZ), a neurogenic niche persisting after birth. Once nested in the SVZ, GSCs can escape a surgical intervention and resist to treatments. The present review will define GSCs and describe their similarities with neural stem cells, residents of the SVZ. The architectural organization of the SVZ will be described both for humans and rodents. The migratory routes taken by GSCs to reach the SVZ and the signaling pathways involved in their migration will also be described hereafter. In addition, we will debate the advantages of the microenvironment provided by the SVZ for GSCs and how this could contribute to tumor recurrences. Finally, we will discuss the clinical relevance of the SVZ in adult GBM and pediatric HGG and the therapeutic advantages of targeting that neurogenic region in both clinical situations.

Identifiants

pubmed: 33575218
doi: 10.3389/fonc.2020.614930
pmc: PMC7870981
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

614930

Informations de copyright

Copyright © 2021 Lombard, Digregorio, Delcamp, Rogister, Piette and Coppieters.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Cancer. 2014 Feb;14(2):92-107
pubmed: 24457416
Eur J Cancer. 2010 Dec;46(18):3383-92
pubmed: 20728344
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Cell Stem Cell. 2010 Aug 6;7(2):163-73
pubmed: 20682445
J Neurosci. 2010 Nov 3;30(44):14635-48
pubmed: 21048121
Ecancermedicalscience. 2020 Mar 26;14:1021
pubmed: 32256704
Neurosurgery. 2020 Jul 1;87(1):E31-E40
pubmed: 32497183
Trends Neurosci. 2014 Mar;37(3):125-35
pubmed: 24388427
Neoplasia. 2011 Sep;13(9):784-91
pubmed: 21969812
Genes (Basel). 2019 Aug 24;10(9):
pubmed: 31450566
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
Oncogene. 2019 Jan;38(1):73-87
pubmed: 30082913
Mol Cell Neurosci. 2013 May;54:44-57
pubmed: 23337036
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):793-800
pubmed: 24495592
Neuro Oncol. 2007 Oct;9(4):424-9
pubmed: 17622647
J Neurooncol. 2012 Aug;109(1):195-203
pubmed: 22555992
Nature. 2005 Oct 6;437(7060):894-7
pubmed: 16208373
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):974-9
pubmed: 19864079
Front Pharmacol. 2016 Dec 07;7:477
pubmed: 28003805
Development. 2019 Feb 18;146(4):
pubmed: 30777863
Am J Pathol. 2018 Jan;188(1):29-38
pubmed: 29024634
BMC Cancer. 2010 Jul 21;10:384
pubmed: 20663133
Oncotarget. 2017 Jul 28;8(44):76644-76655
pubmed: 29100338
Cell Stem Cell. 2020 Feb 6;26(2):277-293.e8
pubmed: 32032526
Pediatr Blood Cancer. 2010 Jul 15;55(1):42-6
pubmed: 20222020
World Neurosurg. 2017 Oct;106:615-624
pubmed: 28729143
Curr Neuropharmacol. 2017;15(1):88-97
pubmed: 27157264
Aging Cell. 2005 Aug;4(4):197-207
pubmed: 16026334
Nat Neurosci. 2008 Nov;11(11):1271-82
pubmed: 18849986
Sci Rep. 2019 Feb 12;9(1):1842
pubmed: 30755636
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8
pubmed: 14595012
Stem Cells. 2017 Apr;35(4):967-980
pubmed: 27870168
Radiat Oncol. 2017 Apr 20;12(1):67
pubmed: 28424082
J Neurooncol. 2014 Jun;118(2):413-419
pubmed: 24668610
Stem Cells. 2004;22(1):109-18
pubmed: 14688397
Neuro Oncol. 2010 Jul;12(7):756-60
pubmed: 20388697
J Neurooncol. 2017 Apr;132(2):341-349
pubmed: 28074322
Neurol Med Chir (Tokyo). 2014;54(4):302-9
pubmed: 24390189
Clin Transl Oncol. 2020 Jul 29;:
pubmed: 32728970
Stem Cells. 2009 Oct;27(10):2383-92
pubmed: 19658181
Cell Stem Cell. 2010 Aug 6;7(2):150-61
pubmed: 20682444
J Neurosurg Pediatr. 2020 May 22;:1-7
pubmed: 32442975
Future Oncol. 2013 Jun;9(6):817-24
pubmed: 23718302
Cell Stem Cell. 2010 Oct 8;7(4):470-82
pubmed: 20887953
Cancer Cell. 2008 Jan;13(1):69-80
pubmed: 18167341
Cancer Cell. 2011 Mar 8;19(3):359-71
pubmed: 21397859
Cell Rep. 2017 Jan 17;18(3):777-790
pubmed: 28099854
Stem Cells. 2007 Oct;25(10):2524-33
pubmed: 17628016
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):609-15
pubmed: 23462418
Biochem J. 2013 Mar 15;450(3):459-68
pubmed: 23301561
Neuro Oncol. 2010 Nov;12(11):1173-86
pubmed: 20716593
J Neurooncol. 2016 Jun;128(2):207-16
pubmed: 27108274
Pediatr Res. 2014 Jan;75(1-2):205-9
pubmed: 24192697
Drug Resist Updat. 2019 Jan;42:35-45
pubmed: 30877905
Pathol Res Pract. 1988 Jun;183(3):356-64
pubmed: 3047716
Lancet Oncol. 2012 Feb;13(2):e83-9
pubmed: 22300863
Nat Rev Neurosci. 2014 Jul;15(7):455-65
pubmed: 24946761
Neuropathol Appl Neurobiol. 2016 Dec;42(7):621-638
pubmed: 27424496
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2579-2584
pubmed: 32196609
Prog Neurobiol. 2018 Nov;170:37-52
pubmed: 29654835
Int J Cancer. 2011 Aug 1;129(3):574-85
pubmed: 20886597
Nature. 2004 Nov 18;432(7015):396-401
pubmed: 15549107
J Neurol Sci. 2020 Jul 15;414:116837
pubmed: 32334273
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):616-22
pubmed: 23540348
Acta Neuropathol. 2014 Oct;128(4):605-7
pubmed: 24929912
J Neurosci Res. 2012 Jun;90(6):1159-68
pubmed: 22344963
Ecancermedicalscience. 2019 Jul 31;13:956
pubmed: 31645884
Cureus. 2018 Nov 21;10(11):e3618
pubmed: 30697499
PLoS One. 2008;3(11):e3769
pubmed: 19020659
Trends Endocrinol Metab. 2016 Nov;27(11):756-769
pubmed: 27387597
Neuron. 2000 Dec;28(3):713-26
pubmed: 11163261
Front Hum Neurosci. 2020 Feb 25;13:472
pubmed: 32161524
Front Neurosci. 2014 Aug 21;8:257
pubmed: 25191221
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389898
Nat Commun. 2020 Jun 19;11(1):3033
pubmed: 32561830
Anat Rec (Hoboken). 2013 Dec;296(12):1850-6
pubmed: 24150861
J Neurooncol. 2017 Jan;131(1):125-133
pubmed: 27644688
Neuron. 2007 Feb 15;53(4):503-17
pubmed: 17296553
J Neurosci. 2010 Mar 3;30(9):3489-98
pubmed: 20203209
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Stem Cells. 2020 Sep;38(9):1159-1174
pubmed: 32442338
Cancer Res. 2007 Jan 15;67(2):651-8
pubmed: 17234775
Front Cell Neurosci. 2014 May 28;8:144
pubmed: 24904289
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
CNS Neurosci Ther. 2020 Apr;26(4):475-485
pubmed: 32187449
Stem Cells. 2010 Jan;28(1):5-16
pubmed: 19904829
Front Neurosci. 2015 Dec 08;9:458
pubmed: 26696816
Neuro Oncol. 2013 Jan;15(1):91-6
pubmed: 23095230
Neurosurg Rev. 2020 Dec;43(6):1583-1593
pubmed: 31705405
Front Biosci (Schol Ed). 2012 Jan 01;4:190-205
pubmed: 22202053
Oncol Lett. 2018 May;15(5):7415-7422
pubmed: 29731893
Annu Rev Neurosci. 2009;32:149-84
pubmed: 19555289
Front Neurol. 2015 Mar 09;6:45
pubmed: 25806019
Cancers (Basel). 2013 Aug 14;5(3):1049-71
pubmed: 24202333
Annu Rev Neurosci. 2005;28:223-50
pubmed: 16022595
Clin Transl Oncol. 2017 Oct;19(10):1225-1231
pubmed: 28389881
J Neurooncol. 2008 Sep;89(2):219-24
pubmed: 18458819
Biochem J. 2017 Aug 11;474(17):2903-2924
pubmed: 28801478
J Oncol. 2012;2012:376894
pubmed: 22685459
Exp Neurol. 2007 Jun;205(2):313-24
pubmed: 17459377
J Neurosurg. 1994 May;80(5):834-9
pubmed: 8169622
J Comp Neurol. 2003 Apr 14;458(4):381-8
pubmed: 12619072
BMC Cancer. 2012 Sep 11;12:406
pubmed: 22967049
Cancer Cell Int. 2013 Aug 21;13(1):85
pubmed: 23961808
Cancer Cell. 2020 May 11;37(5):630-636
pubmed: 32396858
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
J Neurooncol. 2014 Jan;116(2):207-12
pubmed: 24242756
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E1045-54
pubmed: 23431204
J Neurooncol. 2017 Oct;135(1):129-139
pubmed: 28689368
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
pubmed: 14645703
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8754-9
pubmed: 19433789
Development. 2018 Oct 26;145(20):
pubmed: 30237244
Cancers (Basel). 2018 Dec 20;11(1):
pubmed: 30577488
Transl Stroke Res. 2020 Feb;11(1):60-79
pubmed: 31309427
Genes Dev. 2019 Jun 1;33(11-12):591-609
pubmed: 31160393
Genes Dev. 2008 Feb 15;22(4):449-62
pubmed: 18258752
Cancer Res. 2016 Sep 15;76(18):5209-18
pubmed: 27635043
Neuro Oncol. 2015 Jan;17(1):81-94
pubmed: 25085362
J Neurooncol. 2015 Aug;124(1):45-55
pubmed: 26007164
Cell Stem Cell. 2008 Sep 11;3(3):265-78
pubmed: 18786414
Radiat Oncol. 2014 Apr 23;9:95
pubmed: 24758192
Cell. 2017 Aug 24;170(5):845-859.e19
pubmed: 28823557
Nat Commun. 2015 Sep 08;6:8094
pubmed: 26348915
Brain Sci. 2017 Dec 20;7(12):
pubmed: 29261148
Stem Cell Reports. 2017 May 9;8(5):1421-1429
pubmed: 28434940
J Comp Neurol. 2018 Jun 15;526(9):1419-1443
pubmed: 29230807
PLoS One. 2015 Oct 14;10(10):e0140035
pubmed: 26466323
J Chin Med Assoc. 2016 Oct;79(10):538-45
pubmed: 27530866
J Cancer Res Clin Oncol. 2019 Apr;145(4):839-850
pubmed: 30610375
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):722-6
pubmed: 20044217
Cancer Res. 2004 Oct 1;64(19):7011-21
pubmed: 15466194
Stem Cell Reports. 2018 Aug 14;11(2):565-577
pubmed: 29983386
Cancer Res. 2015 Jan 1;75(1):194-202
pubmed: 25406193
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11836-41
pubmed: 22753484
Neuron. 2014 May 7;82(3):545-59
pubmed: 24811379
Neuro Oncol. 2017 Jan;19(1):66-77
pubmed: 27370398
Carcinogenesis. 2020 Jun 17;41(4):417-429
pubmed: 31504251
Cell Mol Life Sci. 2014 Sep;71(18):3465-88
pubmed: 24671641
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Int J Mol Sci. 2019 Mar 08;20(5):
pubmed: 30857245
J Neurooncol. 2020 Jul;148(3):419-431
pubmed: 32562247
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Cancer Res. 2015 Dec 1;75(23):5014-22
pubmed: 26354021
Stem Cells. 2019 Dec;37(12):1629-1639
pubmed: 31430423

Auteurs

Arnaud Lombard (A)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.
Department of Neurosurgery, CHU of Liège, Liège, Belgium.

Marina Digregorio (M)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.

Clément Delcamp (C)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.

Bernard Rogister (B)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.
Department of Neurology, CHU of Liège, Liège, Belgium.

Caroline Piette (C)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.
Department of Pediatrics, Division of Hematology-Oncology, CHU of Liège, Liège, Belgium.

Natacha Coppieters (N)

Laboratory of Nervous System Disorders and Therapy, Groupement Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Neurosciences Research Centre, University of Liège, Liège, Belgium.

Classifications MeSH